MICRODOSING TIRZEPATIDE FOR METABOLIC SUPPORT
A Lower-Dose Approach to Tirzepatide at Intra-V
Not everyone interested in Tirzepatide is looking for aggressive weight loss.
At Intra-V, our Microdose Tirzepatide Membership is designed for clients interested in a lower-dose approach focused on metabolic support, appetite regulation, and maintaining healthy lifestyle habits rather than pursuing a traditional weight-loss dosing protocol.
Our program offers physician-supervised tirzepatide at 1.25 mg or 2.5 mg once per week, depending on your individual needs and medical eligibility.
We call this a metabolic dose, not a weight-loss dose.
If you are interested in the potential metabolic benefits of tirzepatide but do not want to pursue progressively higher weight-loss doses, the Intra-V Microdose Tirzepatide Membership may be an option worth discussing with our medical team.
What Is Microdosing Tirzepatide?
Tirzepatide is a medication that acts on both GIP and GLP-1 receptors, which are involved in metabolic processes including blood sugar regulation, appetite, digestion, and feelings of fullness.
Traditional tirzepatide treatment often involves gradually increasing the dose depending on the patient's condition, treatment goals, response, and tolerance.
Our microdosing approach is different.
Instead of automatically progressing toward higher doses, the Intra-V program uses a consistent low weekly dose of either 1.25 mg or 2.5 mg when medically appropriate.
The goal is not aggressive appetite suppression or rapid weight loss.
The goal is to provide a lower-dose metabolic approach for individuals who may be interested in some of tirzepatide's effects while maintaining their normal nutrition, exercise, and wellness routine.
Potential Benefits of Low-Dose Tirzepatide
Responses to tirzepatide vary from person to person, and lower-dose treatment has not been established as a separate FDA-approved “microdosing” therapy. However, because tirzepatide affects pathways involved in appetite, satiety, glucose regulation, and metabolism, some patients may be interested in a lower-dose approach.
Potential effects may include:
Increased feelings of fullness after meals
Reduced hunger or food cravings
Support for portion control
Support for healthier eating habits
Improved awareness of hunger and satiety cues
Support for glucose and metabolic regulation
An easier-to-maintain approach for patients who do not want aggressive weight loss
Our medical team will help determine whether tirzepatide is appropriate for you and which dose makes sense based on your health history, goals, response, and tolerability.
Metabolic Dose vs. Weight-Loss Dose
This distinction is important.
Intra-V's Microdose Tirzepatide Membership is not designed as a high-dose weight-loss program.
Our program focuses on two lower weekly doses:
1.25 mg Tirzepatide Once Weekly
Our lowest-dose option is intended for patients for whom a provider determines that a very low-dose approach is appropriate.
At 1.25 mg per week, this dose is below the FDA-labeled starting dose for commercially approved tirzepatide products. Its use therefore requires individualized medical evaluation and prescribing.
2.5 mg Tirzepatide Once Weekly
Our second option is 2.5 mg once per week.
While 2.5 mg is the labeled starting dose for FDA-approved tirzepatide products, our program is specifically designed around remaining at a low dose when the treating provider determines that doing so is medically appropriate rather than automatically escalating the dose.
Your provider will determine whether either option is appropriate for you.
Microdosing Tirzepatide in Katy & The Woodlands, TX
Intra-V offers medical wellness services at our locations in Katy, Texas and The Woodlands, Texas, serving patients throughout the Greater Houston area.
If you've been searching for:
microdosing tirzepatide near me, low-dose tirzepatide in Katy TX, tirzepatide metabolic health in The Woodlands, GLP-1 microdosing in Houston, low-dose GLP-1 therapy, or tirzepatide membership programs, contact Intra-V to learn more.
Our team can explain the program, answer your questions, and determine whether you are medically eligible.
Why Microdose Tirzepatide?
There is a growing group of patients who are interested in metabolic health but don't necessarily want significant or rapid weight loss.
You may already exercise regularly.
You may already maintain a healthy diet.
You may be close to your desired weight.
Or you may simply be looking for additional support with appetite, cravings, portion control, or maintaining healthy metabolic habits.
For these patients, continually increasing a medication dose may not align with their goals.
The Intra-V Microdose Tirzepatide Membership was created to offer a different conversation: “What is the lowest appropriate dose that supports your individual goals?”
A Membership Designed for Consistency
Microdose Tirzepatide at Intra-V is offered as a monthly membership subscription.
Rather than treating metabolic health as a one-time appointment, membership allows us to provide ongoing medical oversight and evaluate how you are responding over time.
Your membership is designed to make treatment simple and consistent while keeping your medical team involved throughout the process.
Treatment remains subject to medical evaluation, eligibility, response, and continued provider approval.
Who May Be Interested in Microdosing Tirzepatide?
Our low-dose Tirzepatide program may appeal to adults who:
Are interested in supporting their metabolic health
Want help managing appetite or cravings
Prefer a conservative medication approach
Are not seeking aggressive or rapid weight loss
Want to avoid automatically progressing to higher doses
Already prioritize nutrition and exercise
Want ongoing medical supervision
Are interested in maintaining healthy lifestyle habits over time
Tirzepatide is a prescription medication and is not appropriate for everyone. Every patient must complete an appropriate medical evaluation before treatment.
Why Choose Intra-V?
Intra-V has been providing advanced wellness and medical services to the Houston-area community since 2017.
We are locally owned and operated—not a franchise—and our goal has always been to provide patients with thoughtful, medically supervised wellness options rather than one-size-fits-all programs.
Our Microdose Tirzepatide Membership follows the same philosophy.
Lower dose. Individualized care. Ongoing medical supervision.
Instead of focusing solely on the number on the scale, we can discuss your broader goals and determine whether a low-dose metabolic approach makes sense for you.
Tirzepatide Microdosing Pricing
Simple monthly pricing with no long-term commitment. Your membership renews automatically each month on your signup date, and any unused shots can roll over for future use. Dose changes can be made at the start of a new billing cycle with provider approval.
Need to cancel? Just send us written notice at least 7 days before your next renewal. After cancellation, you’ll have 45 days to use any remaining eligible shots.
Treatment is limited to one shot per week and is always based on our provider’s clinical recommendations.
Click here to view our full Payment & Treatment Agreement for complete details.
MICRODOSING PRICING
1.25mg: $149
2.5mg: $199
1 Shot / Week
(4 shots total)
Microdose Tirzepatide FAQs:
-
Microdosing tirzepatide generally refers to using a dose lower than doses commonly used during standard dose-escalation treatment. “Microdosing” is not an FDA-approved tirzepatide indication or standardized dosing protocol. At Intra-V, our low-dose membership offers 1.25 mg or 2.5 mg weekly when prescribed by a qualified medical provider.
-
The Intra-V program is positioned as a metabolic support program rather than an aggressive weight-loss program. Tirzepatide can affect appetite and body weight, so weight changes are still possible even at lower doses and cannot be predicted for an individual patient.
-
The Microdose Tirzepatide Membership offers 1.25 mg once weekly and 2.5 mg once weekly, subject to medical eligibility and provider approval.
-
Not automatically. Our program is built around a low-dose approach. Your medical provider will evaluate your response, goals, side effects, and overall health to determine the appropriate treatment plan.
-
Tirzepatide acts on GIP and GLP-1 receptors involved in appetite and satiety. Some patients experience decreased appetite, increased fullness, or changes in food intake. Individual responses vary.
-
Tirzepatide is a prescription medication with potential risks, contraindications, drug interactions, and side effects. Common adverse effects can include nausea, diarrhea, vomiting, constipation, abdominal discomfort, and decreased appetite. Serious adverse reactions are also possible.
Tirzepatide products carry a boxed warning regarding the risk of thyroid C-cell tumors observed in rats. It should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Your Intra-V medical provider will review your medical history and determine whether treatment is appropriate.
-
Yes. Tirzepatide is a prescription medication. Medical evaluation and provider approval are required before beginning treatment.
-
The Intra-V Microdose Tirzepatide Membership is available through our Katy and The Woodlands, Texas locations.
Interested in Microdosing Tirzepatide?
You don't have to be looking for dramatic weight loss to start a conversation about metabolic health.
The Intra-V Microdose Tirzepatide Membership offers a lower-dose approach using 1.25 mg or 2.5 mg of tirzepatide once weekly, when prescribed and medically appropriate.
Metabolic support. Lower dosing. Medical supervision.
Schedule your consultation with Intra-V today.
Important Medical Disclaimer
“Microdosing” tirzepatide is not an FDA-approved indication or standardized FDA-approved dosing protocol. A 1.25 mg weekly dose is below the FDA-labeled starting dosage of branded tirzepatide products. For FDA-approved Zepbound, 2.5 mg once weekly is a starting dose and is not an approved maintenance dose for weight reduction.
Treatment decisions are made individually by a licensed medical provider based on medical history, clinical judgment, treatment goals, response, and tolerability. Results vary, and no specific metabolic or weight-loss outcome is guaranteed. This information is for educational purposes and does not replace individualized medical advice.
INTRA-V Services
